# Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy

> **NCT07162454** · NA · COMPLETED · sponsor: **Universidad Complutense de Madrid** · enrollment: 23 (actual)

## Conditions studied

- Xerosis Cutis
- Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** Group 1. Complete formula
- **DRUG:** Group 2. Cannabidiol and Urea 10% formula.
- **DRUG:** Group 3. Placebo formula.

## Key facts

- **NCT ID:** NCT07162454
- **Lead sponsor:** Universidad Complutense de Madrid
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162454, "Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07162454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*